| Literature DB >> 33192450 |
Deng Linghui1, Qiu Shi2,3, Chen Chi4, Liu Xiaolei1, Zhou Lixing1, Zuo Zhiliang1, Dong Birong1.
Abstract
BACKGROUND: Age-related cognitive decline begins in middle age and persists with age. Leukocyte telomere length (LTL) decreases with age and is enhanced by inflammation and oxidative stress. However, whether shorter LTL correlates with cognitive decline remains controversial. AIMS: We aimed to investigate the relationship between LTL and cognitive decline in the American elderly.Entities:
Keywords: aging; biomarker; cognitive decline; elderly; telomere length
Year: 2020 PMID: 33192450 PMCID: PMC7661855 DOI: 10.3389/fnagi.2020.527658
Source DB: PubMed Journal: Front Aging Neurosci ISSN: 1663-4365 Impact factor: 5.750
Baseline characteristics of participants.
| Telomere length (T/S ratio) | Total sample | Q1 (0.389–0.759) | Q2 (0.759–0.880) | Q3 (0.880–1.026) | Q4 (1.026–3.001) | |
| 2,006 | 866 | 558 | 370 | 212 | ||
| Age [mean (SD)] | 70.99 (7.54) | 73.17 (7.96) | 71.09 (7.71) | 69.76 (7.53) | 68.81 (7.30) | <0.001 |
| BMI | 28.78 (6.09) | 28.11 (5.15) | 28.12 (5.69) | 28.29 (5.50) | 28.67 (5.70) | 0.585 |
| Gender | <0.001 | |||||
| Male | 6,614(48.88%) | 470(54.27%) | 289(51.79%) | 156(42.16%) | 84(39.62%) | |
| Female | 6,916(51.12%) | 396(45.73%) | 269(48.21%) | 214(57.84%) | 128(60.38%) | |
| Educational level | 0.447 | |||||
| High school | 6,540(48.34%) | 471(54.39%) | 280(50.18%) | 200(54.05%) | 114(53.77%) | |
| Above high school | 6,990(51.66%) | 395(45.61%) | 278(49.82%) | 170(45.95%) | 98(46.23%) | |
| CAD score [mean (SD)] | 1.20 (1.18) | 1.01 (1.10) | 0.98 (1.09) | 0.91 (0.99) | 1.03 (1.12) | 0.476 |
| Diabetes | 0.238 | |||||
| No | 10,281(78.53%) | 693(82.60%) | 455(84.10%) | 314(87.22%) | 172(82.69%) | |
| Yes | 2,810(21.47%) | 146(17.40%) | 86(15.90%) | 46(12.78%) | 36(17.31%) | |
| Hypertension | 0.509 | |||||
| No | 5,495(40.72%) | 426(49.31%) | 276(49.64%) | 178(48.37%) | 93(43.87%) | |
| Yes | 7,998(59.28%) | 438(50.69%) | 280(50.36%) | 190(51.63%) | 119(56.13%) | |
| Hyperlipidemia | 0.955 | |||||
| No | 12,012(89.68%) | 762(89.96%) | 496(89.69%) | 327(89.59%) | 191(90.95%) | |
| Yes | 1,383(10.32%) | 85(10.04%) | 57(10.31%) | 38(10.41%) | 19(9.05%) | |
| Stroke | 0.556 | |||||
| No | 12,349(91.49%) | 801(92.60%) | 518(93.33%) | 349(94.32%) | 201(94.81%) | |
| Yes | 1,148(8.51%) | 64(7.40%) | 37(6.67%) | 21(5.68%) | 11(5.19%) | |
| Race | 0.002 | |||||
| Mexican American | 1,248(9.22%) | 101(11.66%) | 64(11.47%) | 48(12.97%) | 14(6.60%) | |
| Other Hispanic | 858(6.34%) | 28(3.23%) | 13(2.33%) | 8(2.16%) | 12(5.66%) | |
| Non-Hispanic White | 7,918(58.52%) | 603(69.63%) | 373(66.85%) | 255(68.92%) | 131(61.79%) | |
| Non-Hispanic Black | 2,717(20.08%) | 117(13.51%) | 90(16.13%) | 53(14.32%) | 52(24.53%) | |
| Other Race | 789(5.83%) | 17(1.96%) | 18(3.23%) | 6(1.62%) | 3(1.42%) |
Multivariable linear regressions analysis of the LTL–DSST relationship.
| Exposure | Non-adjusted model | Model I | Model II |
| Telomere length (T/S ratio) | 9.51 (5.82, 13.19), <0.01 | 10.27 (6.83, 13.72), <0.01 | 3.47 (0.14, 6.79), 0.04 |
| Q1 (0.39–0.76) | Reference | Reference | Reference |
| Q2 (0.76–0.88) | 2.93 (1.01, 4.85), <0.01 | 2.87 (1.08, 4.66), 0.01 | 0.88 (−0.81, 2.58), 0.31 |
| Q3 (0.88–1.02) | 4.52 (2.30, 6.73), <0.01 | 4.43 (2.37, 6.50), <0.01 | 1.01 (−0.96, 2.97), 0.32 |
| Q4 (1.02–3.00) | 4.75 (2.02, 7.49), <0.01 | 5.87 (3.32, 8.43), <0.01 | 2.39 (−0.04, 4.82), 0.05 |
| <0.001 | <0.001 | 0.03 |
Effect size of prespecified and exploratory subgroups.
| Characteristic | No. of participants | Effect size (95% CI), | |
| Age | 0.946 | ||
| <70 | 781 | 5.26 (0.24, 10.28), | |
| ≥70 | 864 | 5.02 (0.38, 9.66), | |
| Gender | 0.815 | ||
| Male | 816 | 3.04 (−1.87, 7.95), 0.23 | |
| Female | 829 | 3.04 (−1.87, 7.95), 0.23 | |
| Race | 0.434 | ||
| Mexican American | 176 | −0.13 (−11.76, 11.51), 0.98 | |
| Other Hispanic | 50 | −9.90 (−25.39, 5.59), 0.21 | |
| Non-Hispanic White | 1,152 | 4.06 (0.17, 7.95), | |
| Non-Hispanic Black | 229 | 6.26 (−2.23, 14.75), 0.15 | |
| Other race | 38 | 5.85 (−26.79, 38.50), 0.73 | |
| CAD score | 0.583 | ||
| <3 | 1,463 | 3.73 (0.18, 7.29), | |
| ≥3 | 182 | 1.01 (−8.16, 10.18), 0.83 | |
| Educational level | 0.206 | ||
| High school | 845 | 5.27 (0.92, 9.63), | |
| Above high school | 800 | 1.10 (−3.85, 6.06), 0.66 | |
| BMI | 0.480 | ||
| Lower | 439 | 1.80 (−4.03, 7.62), 0.55 | |
| Higher | 1,206 | 4.30 (0.32, 8.27), |